Neutralizing Interleukin-4 Prevents Transplant Arteriosclerosis Mediated by Indirect Pathway T Cells Under CD40-CD154 Costimulation Blockade

被引:1
作者
Spriewald, Bernd M. [1 ]
Ensminger, Stephan M. [2 ]
Bushell, Andrew [3 ]
Wood, Kathryn J. [3 ]
机构
[1] Univ Erlangen Nurnberg, Dept Internal Med Hematol Oncol 5, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Ctr Cardiac Surg, D-91054 Erlangen, Germany
[3] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
Transplant arteriosclerosis; Vasculopathy; Costimulation; Aortic allograft; Indirect allorecognition; Interleukin-4; Eosinophil; Chronic rejection;
D O I
10.1097/TP.0b013e31818bbd3a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Blockade of the CD40-CD154 costimulatory pathway can prolong allograft survival, but does not prevent the development of transplant arteriosclerosis in several models. In this study, we investigated the mechanisms of CD40-CD154-independent transplant arteriosclerosis in major histocompatibility complex (MHC)-class I-mismatched aortic allografts. Methods. MHC class I-mismatched CBK (H2(k) + K-b) donor aortas were transplanted into CBA (H2(k)) recipients who can only recognize the graft through CD8(+) T cells and CD4(+) T cells responding to the class I MHC mismatch through the indirect pathway of allorecognition. Recipients were treated with anti-CD154 antibody (MR1) alone or in combination with anti-CD8 (YTS169) or anti-interleukin (IL)-4 (11B11) antibodies. Grafts were analyzed by histology on days 30 and 60 and for intragraft mRNA expression on day 14 after transplantation. Results. Repeated treatment with anti-CD154 alone or in combination with anti-CD8 antibody did not prevent intimal proliferation compared with untreated controls (65%+/- 6%, 62%+/- 9%, and 71%+/- 7% luminal occlusion, respectively, 60 days after transplantation). In both treatment groups, the expression of IL-4, IL-5, and eotaxin was increased compared with control grafts, and an eosinophilic infiltration was observed. Neutralizing IL-4 in combination with CD40-CD154 blockade and CD8(+) T-cell depletion abrogated transplant arteriosclerosis (9%+/- 4% luminal occlusion 60 days after transplantation). Conclusion. Prolonged treatment with anti-CD154 was not able to prevent the development of transplant arteriosclerosis in MHC class I-mismatched aortic allografts, in the presence or absence of CD8(+) T cells. This CD40-CD154 pathway resistant transplant arteriosclerosis was mediated by IL-4, because neutralizing IL-4 in addition to CD40-CD154 costimulation blockade and CD8(+) T-cell depletion prevented its development.
引用
收藏
页码:1615 / 1621
页数:7
相关论文
共 47 条
[31]   Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade [J].
Monk, NJ ;
Hargreaves, REG ;
Marsh, JE ;
Farrar, CA ;
Sacks, SH ;
Millrain, M ;
Simpson, E ;
Dyson, J ;
Jurcevic, S .
NATURE MEDICINE, 2003, 9 (10) :1275-1280
[32]   The IL-4 receptor: Signaling mechanisms and biologic functions [J].
Nelms, K ;
Keegan, AD ;
Zamorano, J ;
Ryan, JJ ;
Paul, WE .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :701-738
[33]   Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: Evidence for tolerogenicity of donor resting B cells in vivo [J].
Niimi, M ;
Hava, M ;
Witzke, O ;
Morris, PJ ;
Wood, KJ .
TRANSPLANTATION, 1998, 66 (12) :1786-1792
[34]   Quantification of murine cytokine mRNAs using real time quantitative Reverse Transcriptase PCR [J].
Overbergh, L ;
Valckx, D ;
Waer, M ;
Mathieu, C .
CYTOKINE, 1999, 11 (04) :305-312
[35]   Expression and purification of antigenically active soluble derivatives of the heterodimeric and homodimeric forms of the mouse CD8 lymphocyte membrane glycoprotein [J].
Pellicci, DG ;
Kortt, AA ;
Sparrow, LG ;
Hudson, PJ ;
Sorensen, HV ;
Davis, SJ ;
Classon, BJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 246 (1-2) :149-163
[36]   The eosinophil [J].
Rothenberg, Marc E. ;
Hogan, Simon P. .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :147-174
[37]   Inability to induce tolerance through direct antigen presentation [J].
Rulifson, IC ;
Szot, GL ;
Palmer, E ;
Bluestone, JA .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (06) :510-519
[38]   The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression [J].
Sánchez-Fueyo, A ;
Domenig, C ;
Strom, TB ;
Zheng, XX .
TRANSPLANTATION, 2002, 74 (06) :898-900
[39]   Eosinophils function as antigen-presenting cells [J].
Shi, HZ .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 76 (03) :520-527
[40]   Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis [J].
Shimizu, K ;
Schönbeck, U ;
Mach, F ;
Libby, P ;
Mitchell, RN .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :3506-3518